Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Leukemia Research|July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine AC Kelaidi, T Braun, R Arana, et al.
British Journal of Haematology|May 10, 2006
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II studyL Mannone, C Gardin, M C Quarre, et al.
Leukemia|July 1, 2017
Preclinical modeling of myelodysplastic syndromesK Rouault-Pierre, S A Mian, M Goulard, et al.
Leukemia Research|December 20, 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?R Itzykson, S Thépot, O Beyne-Rauzy, et al.
Nucleic Acids Research|February 21, 1998
Marfan Database (third edition): new mutations and new routines for the softwareG Collod-Béroud, C Béroud, L Ades, et al.
The British Journal of Dermatology|January 11, 2014
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidityM Jachiet, A de Masson, R Peffault de Latour, et al.
Leukemia|January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 casesR Itzykson, S Ayari, D Vassilief, et al.
Leukemia|November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyS de Botton, M A Sanz, S Chevret, et al.
Leukemia|November 27, 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceL Ades, S Chevret, S De Botton, et al.
Leukemia|January 29, 2015
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNetE Lengfelder, F Lo-Coco, L Ades, et al.
Pageof 3